MARK2 Polyclonal Antibody

MARK2 encodes a member of the Par-1 family of serine/threonine protein kinases. Serine/threonine-protein kinase MARK2 is an important regulator of cell polarity in epithelial and neuronal cells, and also controls the stability of microtubules through phosphorylation and inactivation of several microtubule-associating proteins. The protein localizes to cell membranes. Multiple transcript variants encoding different isoforms have been found for this gene.

The MARK2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of MARK2 protein expression in various biological samples. This antibody is produced using advanced recombinant technology, ensuring high purity and quality.

MARK2, also known as Microtubule Affinity Regulating Kinase 2, is a serine/threonine kinase that plays a crucial role in regulating microtubule dynamics and cellular processes such as cell polarity, cell migration, and cell division. Dysregulation of MARK2 has been implicated in various diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases.

The MARK2 Polyclonal Antibody has been extensively validated for its specificity and sensitivity in various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results.

This antibody is supplied as a liquid formulation in a convenient size, allowing for easy handling and storage. It is provided in a ready-to-use format, eliminating the need for time-consuming and complex preparation steps.

With its exceptional performance and reliability, the MARK2 Polyclonal Antibody is an indispensable tool for researchers and scientists studying the role of MARK2 in cellular processes and disease pathogenesis.